PlainRecalls
FDA Drug Moderate Class II Terminated

niCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 x 10 mL Single Dose Vials, Rx Only, For Intravenous Use Only, Mfd for: Civica, Inc., Lehi, UT 84043; Mfd by: American Regent, Inc., New Albany, OH 43054. NDC 72572-470-10

Reported: May 29, 2024 Initiated: May 14, 2024 #D-0503-2024

Product Description

niCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 x 10 mL Single Dose Vials, Rx Only, For Intravenous Use Only, Mfd for: Civica, Inc., Lehi, UT 84043; Mfd by: American Regent, Inc., New Albany, OH 43054. NDC 72572-470-10

Reason for Recall

Lack of Assurance of Sterility.

Details

Recalling Firm
American Regent, Inc.
Units Affected
4,136 cartons (10 vials in each carton)
Distribution
UT only
Location
New Albany, OH

Frequently Asked Questions

What product was recalled?
niCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 x 10 mL Single Dose Vials, Rx Only, For Intravenous Use Only, Mfd for: Civica, Inc., Lehi, UT 84043; Mfd by: American Regent, Inc., New Albany, OH 43054. NDC 72572-470-10. Recalled by American Regent, Inc.. Units affected: 4,136 cartons (10 vials in each carton).
Why was this product recalled?
Lack of Assurance of Sterility.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 29, 2024. Severity: Moderate. Recall number: D-0503-2024.